PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50223C00010DoD DoD covid-19 injector SETS contract — Apiject Systems America, Inc

Apiject Systems America, Inc holds — across 3 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Jul 2, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Daappo/Orm Hq
Awarding office
Apiject Systems America, Inc
Recipient
Jul 2, 2027
PoP end
$19.3M
Obligated
$19.3M
Potential
339999
NAICS
6515
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Apiject Systems America, Inc — $90

Contract facts

NONE
Contract number75A50223C00010
AgencyAspr/Daappo/Orm Hq
Awarding officeAspr/Daappo/Orm Hq
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentApiject Systems America, Inc
CAGE8KFH9
UEIG9VQESMM8525
NAICS339999

No full NAICS 339999 intel page yet. Browse NAICS intelligence

PSC6515
Place of performanceSTAMFORD CT
Pricing typeFirm Fixed Price
Extent competedNot Competed
PoP startMay 8, 2020
PoP end (current)Jul 2, 2027
Obligated$19.3M
Current value$19.3M
Potential value$19.3M

COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022. is a federal NONE award for Aspr/Daappo/Orm Hq held by Apiject Systems America, Inc. Estimated value $19.3M ($19.3M obligated). Current period of performance ends Jul 2, 2027. Last award drew 1 bidder. Place of performance: STAMFORD CT.

COVID-19 INJECTOR SETS CONTRACT TRANSITIONING FROM THE DOD/AF TO HHS/ASPR. DOD/AF CONTRACT NO.FA872620C0022.

Recompete timing

Public
Expiring in 316 days

Current PoP ends Jul 2, 2027 (316 days remaining). Agencies typically plan 12–18 months ahead — at 10.4 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Apiject Systems America, Inc obligated across 3 awards (firm-wide, all agencies).

Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50223C00010?

75A50223C00010 (DoD DoD covid-19 injector SETS contract) is a Aspr/Daappo/Orm Hq award with a potential value of $19.3M, currently held by Apiject Systems America, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50223C00010?

Aspr/Daappo/Orm Hq awarded 75A50223C00010 to Apiject Systems America, Inc (potential $19.3M).

Who is the incumbent on 75A50223C00010?

Apiject Systems America, Inc is the incumbent with — across 3 related awards in SCOUT’s public footprint. The current period of performance ends Jul 2, 2027.

When does Apiject Systems America, Inc’s 75A50223C00010 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 2, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50223C00010